Search the LJMU website

1. What supplements do scientists use and why?

   Six scientists share their supplement recommendations.

2. Groundhog Day or liberation from daily routine?

   Dr Ruth Odgen from the School of Psychology, a lead investigator on a new study into time under COVID-19 isolation, shares her thoughts with us.

3. Human ancestors had the same dental problems as us – even without fizzy drinks and sweets

   Prehistoric humans and their predecessors may have had a very different diet but their teeth suffered in similar ways to ours, writes anthropology lecturer Dr Ian Towle

4. More vital now than ever: My research on Andrea Levy

   Dr Michael Perfect, a Senior Lecturer in English Literature, discusses his research on author Andrea Levy.

5. Will genetically modified pets soon be reality or do they already live among us?

   Demelza Kooij's film The Breeder considers the darker implications of our cultural fetish with cute.

6. What supplements do scientists use, and why?

   Six scientists, including LJMU Professor of Human Physiology Graeme Close, on the supplements they take every day and why they take them

7. Trans Awareness Week and Trans Day of Remembrance

   As Transgender Awareness Week begins (13 -19th November) and ahead of Transgender Day of Remembrance (20 November), Dr Bee Hughes (they/them/theirs), LJMU Lecturer in Media, Culture, Communication and Co-Chair of LJMU Together LGBT+ Staff Network looks at the local, national and international picture when it comes to trans awareness and allyship in 2021.

8. LightNight 2019

   Business Studies student Julia Harrison shares her favourite cultural events from Light Night 2019

9. How parasites and bacteria could be changing the way you think and feel

   From losing inhibitions to dementia – Lecturer in Genetics Dr Robbie Rae explores the role small critters play in a range of illnesses and behaviours

10. Prescription drugs pregabalin and gabapentin have been reclassified – but it won’t stop problem use

    Prescription drugs pregabalin and gabapentin have been reclassified – but it won’t stop problem use